Close Menu

NEW YORK ─ Biocartis on Thursday reported 68 percent growth in year-over-year commercial cartridge volume for the first quarter of 2020.

Mechelen, Belgium-based Biocartis also said that in Q1, it saw slower than expected installed base expansion due to the COVID-19 pandemic, with the main impact occurring in Southern European, US, and rest of the world markets.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.